Abiraterone Acetate Plus Prednisone in Black and White Men With Metastatic Castrate-Resistant Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
A Prospective Trial of Abiraterone Acetate Plus Prednisone in Black and White Men With Metastatic Castrate-Resistant Prostate Cancer
Cancer 2021 May 05;[EPub Ahead of Print], DJ George, S Halabi, EI Heath, AO Sartor, GP Sonpavde, D Das, RL Bitting, W Berry, P Healy, M Anand, C Winters, C Riggan, J Kephart, R Wilder, K Shobe, J Rasmussen, MI Milowsky, MT Fleming, J Bearden, M Goodman, T Zhang, MR Harrison, M McNamara, D Zhang, BL LaCroix, RA Kittles, BM Patierno, AB Sibley, SR Patierno, K Owzar, T Hyslop, JA Freedman, AJ ArmstrongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.